NCT04115995

Brief Summary

Patients selected for DIEP breast reconstruction were examined with preoperative CTA, Doppler Ultrasound, dynamic infrared thermography (DIRT) and Indocyanin green fluorescent angiography (ICG-FA) for perforator mapping. DIRT and ICG-FA were used to evaluate perfusion of selected perforators. Following anastomoses for the DIEP flap to internal mammary vessels , patency of the anastomosis was evaluated with DIRT and ICG-FA. Recorded images from all the modules were compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 16, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2019

Completed
6 months until next milestone

First Posted

Study publicly available on registry

October 4, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2019

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

October 4, 2019

Status Verified

December 1, 2018

Enrollment Period

11 months

First QC Date

April 16, 2019

Last Update Submit

October 3, 2019

Conditions

Keywords

Breast reconstructionPerforator flapsComputer TomographyIndocyanine greenFluorescence angiographyInfrared thermographyDynamic infrared thermographyDoppler ultrasoundAngiosomePerforasomeFlap perfusion

Outcome Measures

Primary Outcomes (2)

  • Assessment of quality and location of perforating blood vessels with dynamic infrared thermography and indocyanine green angiography in autologous breast reconstruction: A comparative imaging study.

    Pre-and intraoperative use of two different imaging technologies to assess quality and location of perforating blood vessels in autologous breast reconstruction. In this study we will compare images obtained using a non-invasive imaging technique, dynamic infrared thermography and an invasive imaging technique, laser fluorescence angiography of indocyanine green.

    2 year

  • Quality of microvascular anastomosis by measuring perfusion through the anastomosis using dynamic infrared thermography and laser fluorescence angiography of indocyanine green.

    The microvascular anastomosis provides blood supply to tissue used in breast reconstruction. The blood flow through the microvascular anastomosis can be monitored by use of different imaging techniques. In this study, perfusion images obtained by non-invasive dynamic infrared thermography and invasive fluorescence angiography of indocyanine green will be compared.

    2 years

Interventions

DIRT and ICG FA are used intraoperatively to evaluate perfusion of the perforators and the anastomosis. Both technique are compared in their ability to visualize perfusion.

Eligibility Criteria

Age25 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female patients are included for breast reconstruction after treatment for breast cancer.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female patients selected for autologous breast reconstruction with a DIEP flap.

You may qualify if:

  • Post mastectomy.
  • Previously breast cancer patent treated with radiation therapy.
  • Breast implant reconstruction is not possible or undesired.
  • Healthy patient with moderate amounts of abdominal skin laxity.
  • Patient who requires a minimal to moderate volume breast reconstruction.
  • The patient willing to undergo the long, complex procedure and prolonged postoperative recovery.
  • The patient willing to accept an abdominal scar and a potential for donor site morbidities.
  • Patients operated with prophylactic salpingo-oophorectomy due to BRCA gene mutation.

You may not qualify if:

  • Pregnancy and lactation.
  • Patents below the age of 18 year.
  • Renal failure or hepatic failure.
  • Previous allergic reactions to ICG and iodide.
  • Abdominal donor site that cannot be closed primarily.
  • Previous TRAM flap or abdominoplasty.
  • Significant medical comorbidities that make the patient a poor surgical candidate.
  • Sigarette smoking or snuff.
  • Obesity / BMI \> 30.
  • Previous abdominal suction-assisted lipectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univesity Hospital of North Norway

Tromsø, 9038, Norway

RECRUITING

Central Study Contacts

Louis de Weerd, MD, PhD,

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2019

First Posted

October 4, 2019

Study Start

January 16, 2019

Primary Completion

December 24, 2019

Study Completion

December 31, 2019

Last Updated

October 4, 2019

Record last verified: 2018-12

Locations